Allgenesis DRC A Multicenter, Prospective, Randomized, Double-masked Study Evaluating the Safety, Tolerability, and Efficacy of Topical AG-86893 in Patients with Pterygium

Administered By

Awarded By

Contributors

Start/End

  • June 12, 2018 - July 31, 2020